Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David M Kofler

Showing results (11-20 of 44) with videos related to

Pageof 5
Sort By:
Pneumologie (Stuttgart, Germany)|September 14, 2022
[Latest news on RA-ILD]Tina Schreiber, Lars Hagmeyer, David M Kofler, et al.
Blood|July 15, 2005
Transduction of CLL cells by CD40 ligand enhances an antigen-specific immune recognition by autologous T cellsChristine Mayr, David M Kofler, Hildegard Büning, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 19, 2011
The CD6 multiple sclerosis susceptibility allele is associated with alterations in CD4+ T cell proliferationDavid M Kofler, Christopher A Severson, Narine Mousissian, et al.
Blood|October 9, 2004
Fibromodulin as a novel tumor-associated antigen (TAA) in chronic lymphocytic leukemia (CLL), which allows expansion of specific CD8+ autologous T lymphocytesChristine Mayr, Dagmar Bund, Martin Schlee, et al.
The Journal of Clinical Investigation|May 10, 2014
Decreased RORC-dependent silencing of prostaglandin receptor EP2 induces autoimmune Th17 cellsDavid M Kofler, Alexander Marson, Margarita Dominguez-Villar, et al.
Experimental Hematology|January 18, 2006
MDM2 is recognized as a tumor-associated antigen in chronic lymphocytic leukemia by CD8+ autologous T lymphocytesChristine Mayr, Dagmar Bund, Martin Schlee, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|October 9, 2022
High increase in levels of lipoprotein(a) in plasma of patients with rheumatoid arthritis after COVID-19David Stahl, Ruth L Esser, Carolin Brück, et al.
RMD Open|October 10, 2022
Reduced humoral response to a third dose (booster) of SARS-CoV-2 mRNA vaccines by concomitant methotrexate therapy in elderly patients with rheumatoid arthritisDavid Stahl, Carola Tho Pesch, Carolin Brück, et al.
Annals of the Rheumatic Diseases|November 21, 2019
Regulatory T cell frequencies in patients with rheumatoid arthritis are increased by conventional and biological DMARDs but not by JAK inhibitorsAnja Meyer, Paula S Wittekind, Konstantin Kotschenreuther, et al.
Blood|September 24, 2005
Chromosomal translocations are associated with poor prognosis in chronic lymphocytic leukemiaChristine Mayr, Michael R Speicher, David M Kofler, et al.
Pageof 5

Showing results (11-20 of 44) with videos related to

Sort By:
Pageof 5
Pneumologie (Stuttgart, Germany)|September 14, 2022
[Latest news on RA-ILD]Tina Schreiber, Lars Hagmeyer, David M Kofler, et al.
Blood|July 15, 2005
Transduction of CLL cells by CD40 ligand enhances an antigen-specific immune recognition by autologous T cellsChristine Mayr, David M Kofler, Hildegard Büning, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 19, 2011
The CD6 multiple sclerosis susceptibility allele is associated with alterations in CD4+ T cell proliferationDavid M Kofler, Christopher A Severson, Narine Mousissian, et al.
Blood|October 9, 2004
Fibromodulin as a novel tumor-associated antigen (TAA) in chronic lymphocytic leukemia (CLL), which allows expansion of specific CD8+ autologous T lymphocytesChristine Mayr, Dagmar Bund, Martin Schlee, et al.
The Journal of Clinical Investigation|May 10, 2014
Decreased RORC-dependent silencing of prostaglandin receptor EP2 induces autoimmune Th17 cellsDavid M Kofler, Alexander Marson, Margarita Dominguez-Villar, et al.
Experimental Hematology|January 18, 2006
MDM2 is recognized as a tumor-associated antigen in chronic lymphocytic leukemia by CD8+ autologous T lymphocytesChristine Mayr, Dagmar Bund, Martin Schlee, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|October 9, 2022
High increase in levels of lipoprotein(a) in plasma of patients with rheumatoid arthritis after COVID-19David Stahl, Ruth L Esser, Carolin Brück, et al.
RMD Open|October 10, 2022
Reduced humoral response to a third dose (booster) of SARS-CoV-2 mRNA vaccines by concomitant methotrexate therapy in elderly patients with rheumatoid arthritisDavid Stahl, Carola Tho Pesch, Carolin Brück, et al.
Annals of the Rheumatic Diseases|November 21, 2019
Regulatory T cell frequencies in patients with rheumatoid arthritis are increased by conventional and biological DMARDs but not by JAK inhibitorsAnja Meyer, Paula S Wittekind, Konstantin Kotschenreuther, et al.
Blood|September 24, 2005
Chromosomal translocations are associated with poor prognosis in chronic lymphocytic leukemiaChristine Mayr, Michael R Speicher, David M Kofler, et al.
Pageof 5